A groundbreaking study by Johns Hopkins Medicine has uncovered a possible connection between hepatitis C virus (HCV) infections and serious psychiatric conditions like schizophrenia and bipolar disorder. Published in Translational Psychiatry<\/em>, the research revealed that HCV is present in the brain\u2019s choroid plexus\u2014a structure that produces cerebrospinal fluid and helps regulate immune activity in the brain\u2014but not in the brain tissue itself.<\/p>\n\n\n\n This finding supports the long-standing theory that infections may play a hidden role in psychiatric illnesses. \u201cSome people with symptoms of bipolar disorder or schizophrenia may actually have a hepatitis C infection instead,\u201d said lead researcher Dr. Sarven Sabunciyan, a neuroscientist at Johns Hopkins. \u201cPotentially, treating the viral infection will improve the psychiatric symptoms in these people.\u201d<\/p>\n\n\n\n Using viral RNA sequencing technology, researchers analyzed brain samples from 256 deceased individuals\u2014some with schizophrenia, bipolar disorder, or major depression, and others without psychiatric diagnoses. They focused specifically on the choroid plexus, a structure known to be vulnerable to infection. Out of more than 3,000 viruses tested, HCV was the only one significantly associated with schizophrenia and bipolar disorder.<\/p>\n\n\n\n The results were striking: HCV was found exclusively in the choroid plexus of people with these disorders, never in healthy individuals or those with depression. The team then analyzed health records of 285 million patients. They discovered HCV prevalence was 3.6% in people with schizophrenia and 3.9% in those with bipolar disorder. This compared to 1.8% for major depression and just 0.5% for those without psychiatric conditions.<\/p>\n\n\n\n These numbers, the researchers argue, suggest that the relationship between HCV and mental illness isn\u2019t just due to behaviors like intravenous drug use, which are common across all three psychiatric groups. Instead, the virus itself may be contributing to disease pathology.<\/p>\n\n\n\n The choroid plexus forms the blood-cerebrospinal fluid barrier\u2014a critical checkpoint that keeps harmful substances out of the brain. But it’s also a target for viruses. When HCV infects this area, it doesn\u2019t need to enter the brain directly to cause problems. According to Sabunciyan\u2019s team, the virus appears to trigger changes in gene expression in nearby brain regions, particularly the hippocampus, which controls memory and emotion.<\/p>\n\n\n\n Though HCV wasn\u2019t detected in the hippocampus itself, samples from infected individuals showed dramatic changes in brain gene activity. Specifically, the presence of HCV in the choroid plexus was linked to the suppression of certain repetitive genetic elements\u2014especially Alu and L1 sequences\u2014that are involved in regulating immune response and brain function. This suggests a possible immune-triggered mechanism where the body\u2019s reaction to the virus may alter brain chemistry.<\/p>\n\n\n\n While the study does not prove that clearing the virus will reverse psychiatric symptoms, the researchers are optimistic. Past studies have shown that antiviral treatment for HCV can improve cognitive symptoms and reduce brain inflammation. One Taiwanese study even reported a reduced risk of developing schizophrenia in patients treated with antiviral drugs.<\/p>\n\n\n\n \u201cOur findings show that it\u2019s possible some people may be having psychiatric symptoms because they have an infection,\u201d Sabunciyan said. \u201cAnd since hepatitis C is treatable, it might be possible for this patient subset to be treated with antivirals and not have to deal with psychiatric symptoms.\u201d<\/p>\n\n\n\n The researchers suggest that screening for HCV should become routine in psychiatric care, especially for patients with schizophrenia or bipolar disorder. \u201cGiven that the worldwide rate of schizophrenia and bipolar disorder is around 1 and 3 percent respectively, identifying and treating HCV in even a small subset of these patients could help hundreds of thousands of people,\u201d Sabunciyan said.<\/p>\n\n\n\n Further investigations are already underway to determine whether the presence of HCV or other viruses in cerebrospinal fluid could serve as a biomarker for psychiatric disease. The team also plans to explore if other viruses that hide in the brain\u2019s lining may have similar effects.<\/p>\n\n\n\n The findings have reignited interest in the \u201cviral hypothesis\u201d of mental illness\u2014a theory that infections may cause or contribute to psychiatric disorders by altering immune function or damaging the brain. While the idea has long been debated, this study provides some of the most direct evidence yet.<\/p>\n\n\n\n \u201cThis is a very elegant study,\u201d commented Dr. Jessica Faccioli, a neurologist who has written extensively on HCV-related brain disorders. \u201cIt not only reinforces the role of neuroinflammation in psychiatric disease, but also shows us a potential path forward: treat the infection, and you might relieve the symptoms.\u201d<\/p>\n\n\n\n Up to 50% of people with chronic HCV infection experience neurological or psychiatric symptoms such as fatigue, depression, or cognitive decline, even when liver damage is mild or absent. Many of these patients may never realize that their brain fog or mood swings are connected to a viral infection.<\/p>\n\n\n\n The authors emphasize the importance of universal HCV screening, especially in psychiatric patients. \u201cOur work highlights a blind spot in mental health care,\u201d Sabunciyan said. \u201cWe need to start considering that infections like HCV might not just be side effects of risky behavior, but actual drivers of disease.\u201d<\/p>\n\n\n\n The team\u2019s next steps include analyzing cerebrospinal fluid for viral signatures, studying more brain regions, and testing whether antiviral treatment can reverse psychiatric symptoms in infected patients. If confirmed, this research could reshape the way doctors understand\u2014and treat\u2014serious mental illnesses.<\/p>\n\n\n\n For now, the message is clear: for a subset of patients battling disorders like schizophrenia and bipolar disorder, the road to recovery might begin not with a new psychiatric drug, but with an old antiviral one.<\/p>\n","protected":false},"excerpt":{"rendered":" Discovery Links Virus to Schizophrenia and Bipolar Disorder A groundbreaking study by Johns Hopkins Medicine has uncovered a possible connection between hepatitis C virus (HCV) infections and serious psychiatric conditions like schizophrenia and bipolar disorder. Published in Translational Psychiatry, the research revealed that HCV is present in the brain\u2019s choroid plexus\u2014a structure that produces cerebrospinal fluid and helps regulate immune activity in the brain\u2014but not in the brain tissue itself. This finding supports the long-standing theory that infections may play […]<\/p>\n","protected":false},"author":2,"featured_media":6898,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,9,11],"tags":[],"class_list":["post-6897","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-conditions","category-mental-health","category-sex"],"_links":{"self":[{"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/posts\/6897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/healthnews.zone\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6897"}],"version-history":[{"count":1,"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/posts\/6897\/revisions"}],"predecessor-version":[{"id":6899,"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/posts\/6897\/revisions\/6899"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/healthnews.zone\/index.php?rest_route=\/wp\/v2\/media\/6898"}],"wp:attachment":[{"href":"https:\/\/healthnews.zone\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/healthnews.zone\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/healthnews.zone\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What the Research Team Found<\/h3>\n\n\n\n
How a Liver Virus Reaches the Brain<\/h3>\n\n\n\n
Are the Effects Reversible?<\/h3>\n\n\n\n
Implications for Diagnosis and Treatment<\/h3>\n\n\n\n
A Call for Broader Screening<\/h3>\n\n\n\n